Differences

This shows you the differences between two versions of the page.

--- home:diseases:diabetes2 [02.19.2019] – [Antimicrobial therapy in insulin resistance/type 2 diabetes] sallieq
+++ home:diseases:diabetes2 [07.10.2019] – [Research] sallieq
@@ Line 12: / Line 12: @@
 Major long term symptoms and effects of diabetes include retinopathy, neuropathy, nephropathy, congitive dysfunction, foot sores and amputations of limbs.
-===== Recent Research =====
+===== Research =====
@@ Line 29: / Line 29: @@
 Our results illustrate that macrophage A2bAR signaling is needed and sufficient for relaying the protective effect of the A2bAR against HFD-induced tissue inflammation and insulin resistance in mice.  (({{pubmed>long:24892847}}))
+This trial aims to determine the effects of resistant starch (RS) subtype 2 (RS2) on glycemic status, metabolic endotoxemia and markers of oxidative stress.  (({{pubmed>long:    26655398}}))
+Among persons at high risk for type 2 diabetes not selected for vitamin D insufficiency, vitamin D3 supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo. (({{pubmed>long:31173679}}))
@@ Line 160: / Line 164: @@
-{{tag>diseases arrange}}
+{{tag>diseases }}

home/diseases/diabetes2.txt · Last modified: 09.14.2022 by 127.0.0.1